Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

Contact
Request a demo
Request data updates
Add a company

Research

Companies
Investors
People

aVenture

Sitemap
Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage

Loading

Home›Research›Companies

Companies

Loading

Aurie

AddedMay 3, 2026

UpdatedJul 6, 2026

Aurie

Aurie develops reusable no-touch catheters that improve health and independence for people with disabilities.

HQ

Syracuse, NY, US

Founded

Aurie is developing the first-ever automatically reusable catheter system designed to reduce urinary tract infection risks for intermittent catheter users. The system features a no-touch design with a Personal Disinfector that cleans, disinfects, and lubricates the catheter in 36 minutes.

Founded in 2018 and based in Syracuse, New York, Aurie partners with the disabled community to create medical devices that address significant unmet needs. The company targets approximately 600,000 American users and is expanding internationally.

Aurie - Similar Companies

Ur24Technology

ur24technology.com

CathConnect

cathconnect.com

Sterifre Medical

sterifre.com

Aurea Medical

UroCure

urocure.com

Luvaura

J & M Urinary Catheters

Auvi Labs

auvilabs.com

Poiesis Medical

poiesismedical.com

Bright Uro

brighturo.com

Levity Products

levityproducts.com

SBE Medical

tibbe.us

Puracath Medical

puracath.com

Assist Equipment Development

aedevelopment.us

Auricle

auricle.com

Aurie - Quick Facts

Who are Aurie's competitors?

Companies similar to Aurie include Ur24Technology, CathConnect, Sterifre Medical and Aurea Medical.

When was Aurie founded?

Aurie was founded in 2018.

Where is Aurie's headquarters located?

Aurie's headquarters is located in Syracuse, NY, US.

When was Aurie's last funding round?

Aurie's most recent funding round was for $9.1M (USD) in April 2024.

How much has Aurie raised to-date?

As of Apr 4, 2024, Aurie has raised a total of $11.3M (USD).

How many employees does Aurie have?

Aurie has 7 employees as of May 3, 2026.

Aurie - Classification

Technology: Medical Device
Geographic Exposure: Americas United States

Customer: Individuals
Main Product: Assistive Devices

Tags: Healthcare
Medical Devices